Prenatal and Newborn Genetic Testing Market is estimated to reach USD 26.87 billion during the forecast period

The global prenatal and newborn genetic testing market size was valued at USD 7.58 billion in 2023 and is projected to reach USD 26.87 billion by the end of 2032, with a compound annual growth rate (CAGR) of nearly 15.1% between 2024 and 2032.

Prenatal and newborn genetic testing is a group of medical tests performed during pregnancy and after birth to check whether a baby has genetic disorders, inherited diseases, or chromosomal conditions. These tests help doctors identify potential health problems early, often before any symptoms appear, allowing families and healthcare providers to plan appropriate care and treatment. Prenatal and new-born genetic testing uses advanced methods such as DNA testing, blood tests, and biochemical screening to provide accurate information about a baby’s health. Some tests are performed during pregnancy, while others are done soon after the baby is born. The main types include non-invasive prenatal testing (NIPT), invasive prenatal diagnostic tests such as amniocentesis and chorionic villus sampling (CVS), and new-born screening tests. They are widely used by obstetricians, pediatricians, hospitals, diagnostic laboratories, and genetic counselors around the world. These tests have become an important part of modern prenatal and new-born healthcare, helping doctors make informed medical decisions at different stages of pregnancy and early infancy.

The prenatal and newborn genetic testing industry is growing due to rising awareness about genetic disorders, an increasing number of high-risk pregnancies, and the wider adoption of advanced screening technologies across developing economies.

Browse the full “Prenatal and new-born genetic testing Market - By Technology (Screening and Diagnostic), By End-Use (Hospitals, Maternity & Specialty Clinics, and Diagnostic Units), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/prenatal-and-new-born-genetic-testing-market

Market Growth Factors

Several factors are pushing growth in the prenatal and newborn genetic testing market.

• Rising maternal age at childbirth: A growing number of women choosing to conceive later in life is increasing the need for genetic screening due to higher associated risks.
• Increasing awareness about hereditary conditions: Greater public understanding of genetic disorders and their long-term impact is increasing demand for early testing and timely intervention.
• Growth of advanced screening technologies: Expanding availability of non-invasive and highly accurate testing methods is making it easier for parents to access reliable genetic information early in pregnancy.

Restraints

• High cost of advanced genetic tests: Steep prices of comprehensive genetic testing can limit adoption among cost-conscious families in developing regions.
• Ethical and social concerns: Sensitive issues around genetic privacy and decision-making can affect the widespread acceptance of prenatal genetic testing.

Prenatal and new-born genetic testing Market: Report Scope

Market Segmentation

The prenatal and newborn genetic testing market can be segmented by test type, technology, application, end use, and region.

Based on test type, the market is divided into screening tests and diagnostic tests. Screening tests hold the largest market share because they are non-invasive, safer for the mother and baby, and widely recommended as a first step before considering more invasive procedures.

Based on technology, the market is segregated into next-generation sequencing, polymerase chain reaction, microarray, and other technologies. The next-generation sequencing segment leads the market because it offers highly detailed genetic information, faster turnaround times, and the ability to detect a wide range of conditions in a single test.

Based on application, the prenatal and newborn genetic testing market is classified into chromosomal abnormality detection, inherited disorder screening, and other applications. The chromosomal abnormality detection segment accounts for the largest market share because conditions such as Down syndrome remain a major area of concern for expecting parents and healthcare providers alike.

Based on end-use, the prenatal and newborn genetic testing industry is categorized into hospitals, diagnostic laboratories, and specialty clinics. Diagnostic laboratories lead the market because they offer specialized infrastructure, skilled genetic counselors, and faster processing of complex genetic samples.

North America leads the prenatal and newborn genetic testing market because of its advanced healthcare system, high awareness about genetic disorders, and strong demand for early screening during pregnancy. The United States leads the region, with many hospitals, diagnostic laboratories, and maternity care centers offering advanced genetic testing services. Good insurance coverage and government-supported new-born screening programs also encourage more families to choose these tests. Parents are becoming more aware of the benefits of early disease detection, which is helping increase the use of prenatal and newborn genetic testing. Partnerships between hospitals, diagnostic companies, and healthcare providers are expanding access to these services. In addition, the growing use of digital health records and online genetic counseling is making genetic testing easier and more convenient for families across North America.

Key Market Players

Leading companies in the global prenatal and newborn genetic testing market include:

• Natera
• Ariosa Diagnostics (Roche)
• Trivitron Healthcare
• Sequenom
• Berry Genomics
• Qiagen
• BGI
• Bio-Rad
• Illumina
• Laboratory Corporation of America
• Verinata Health

Recent Developments

• In January 2026, Natera Inc. launched its 21-gene Fetal Focus single-gene non-invasive prenatal test (NIPT), supported by results from the EXPAND clinical trial, to enable earlier and more accurate detection of inherited genetic conditions during pregnancy.
• In May 2026, Natera Inc. introduced an enhanced version of its Panorama non-invasive prenatal test using SNP-informed deep sequencing technology, improving performance in low fetal fraction samples and reducing the no-call rate to 0.5%, helping expand access to reliable prenatal genetic screening.

The global Prenatal and new-born genetic testing Market is segmented as follows:

By Technology

• Screening
• Diagnostic

By End-Use

• Hospitals
• Maternity & Specialty Clinics
• Diagnostic Units

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is updated constantly in order to provide our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not least, we make it our duty to ensure the success of clients connected to us—after all, if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com